Hemodynamic effects of heart rate lowering in patients admitted for acute heart failure: the RedRate-HF Study (Reduction of heart Rate in Heart Failure)

Autor: Andrea, Mortara, Jessica, Rossi, Simone, Mazzetti, Francesco, Catagnano, Cristina, Cavalotti, Gianluigi, Malerba, Chiara, Vecchio, Fabrizio, Morandi, Daniele, Nassiacos, Fabrizio, Oliva

Publikováno v: Journal of Cardiovascular Medicine. 24:113-122

In patients admitted for acute heart failure (HF) indication for drugs which reduce the heart rate (HR) is debated. The multicentre prospective study Reduction of heart Rate in Heart Failure (RedRate-HF) was designed to analyse the hemodynamic effect

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0a4ca67e65f20620d66635225c74bf0
https://doi.org/10.2459/jcm.0000000000001427

Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy

Autor: Toni Sarapohja, Fabrizio Morandi, Paola Beltrán, Gerhard Pölzl, Roman Pfister, Matti Kivikko, Piero Pollesello, Johann Altenberger, Dirk von Lewinski, Mirko Seidel, Gian Piero Perna, Josep Comín-Colet, Attila Borbély, Ramón Bover, Martín J. García-González, Friedrich Fruhwald, George Giannakoulas, Loant Baholli, Martin Martínez-Sellés, Alexander Reinecke, Bojan Vrtovec, Juan F. Delgado, Gabriella Malfatto, Alejandro Recio-Mayoral, Josep Masip, Stefan Störk, Fabrizio Oliva, Gregory Giamouzis, Finn Gustafsson, Patrik Yerly, Diego Rangel-Sousa, Kari Kaikkonen, Ida Löfman, Zoltán Papp, Henning Mølgaard, Gunter Schmidt, Nicolás Manito, Antonella Fontana, Francesco Fedele, Gerhard Wikström, Vito Piazza, Emil Pantev, Béla Merkely, Jacek Kubica, Andreas Rieth

Publikováno v: Poelzl, G, Altenberger, J, Baholli, L, Beltran, P, Borbely, A, Comin-Colet, J, Delgado, J F, Fedele, F, Fontana, A, Fruhwald, F, Giamouzis, G, Giannakoulas, G, Garcia-Gonzalez, M J, Gustafsson, F, Kaikkonen, K, Kivikko, M, Kubica, J, von Lewinski, D, Lofman, I, Malfatto, G, Manito, N, Martinez-Selles, M, Masip, J, Merkely, B, Morandi, F, Molgaard, H, Oliva, F, Pantev, E, Papp, Z, Perna, G P, Pfister, R, Piazza, V, Bover, R, Rangel-Sousa, D, Recio-Mayoral, A, Reinecke, A, Rieth, A, Sarapohja, T, Schmidt, G, Seidel, M, Stoerk, S, Vrtovec, B, Wikstroem, G, Yerly, P & Pollesello, P 2017, ' Repetitive use of levosimendan in advanced heart failure : need for stronger evidence in a field in dire need of a useful therapy ', International Journal of Cardiology, vol. 243, pp. 389-395 . https://doi.org/10.1016/j.ijcard.2017.05.081

Patients in the latest stages of heart failure are severely compromised, with poor quality of life and frequent hospitalizations. Heart transplantation and left ventricular assist device implantation are viable options only for a minority, and interm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb92f299208040c61f7984071f0b8ce9
https://doi.org/10.1016/j.ijcard.2017.05.081

Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration

Autor: Renata De Maria, Ivan Caico, Sabina Meloni, Fabrizio Morandi, Chiara Minoia, Daniele Nassiacos, Andrea Lorenzo Vecchi, Gabriella Malfatto, Alessandro Verde, Antonio Cirò, Alessandra Villani, Fabrizio Oliva, Gianpiero Perna, Marco Marini, Enrico Perna, Antonella Vincenzi

Publikováno v: International journal of cardiology. 272

Ambulatory Advanced Heart Failure (AAHF) is characterized by recurrent HF hospitalizations, escalating diuretic requirements, intolerance to neurohormonal antagonists, end-organ dysfunction, short-term reduced life expectancy despite optimal medical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f591aaa8665a9d17cf5833574f1d0da
https://pubmed.ncbi.nlm.nih.gov/30131229

Heart rate as a prognostic marker and therapeutic target in acute and chronic heart failure

Autor: Rachele Contri, Fabrizio Morandi, A. Ciro, Fabrizio Oliva, Paola Sormani, Valentina Carubelli, Giuseppe Di Tano, Marco Metra, Andrea Mortara, Enrico Ammirati, Michele Senni, Carlo Campana

Since increased heart rate (HR) is associated with higher mortality in several cardiac disorders, HR is considered not only a physiological indicator but also a prognostic and biological marker. In heart failure (HF), it represents a therapeutic targ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf05b03b87b6979c2fd6d2de35bfd02b
http://hdl.handle.net/10281/372484

The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations

Autor: Alain Rudiger, Antonio Carlos Pereira-Barretto, Robert Zymliński, Kenneth Dickstein, John Parissis, Igor Yavelov, Loant Baholli, Francesco Fedele, Nenad Karanovic, Robert H. G. Schwinger, Gerhard Wikström, Manfred Wieser, Angel Novoa, Piero Pollesello, José Antonio Magaña Serrano, Fabrizio Morandi, S T Matskeplishvili, Juan E. Mesa, Matti Kivikko, Piergiuseppe Agostoni, Josep Comin Colet, Dulce Brito, Vojka Gorjup, István Édes, Eduardo Heberto Herrera Garza, Markku S. Nieminen, Igor Katsytadze, Béla Merkely, Apostolos Karavidas, Jose Ramon Gonzalez Juanatey, Shaul Atar, Fabrizio Oliva, Petr Ostadal, Cândida Fonseca

Publikováno v: International Journal of Cardiology
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP

End of life is an unfortunate but inevitable phase of the heart failure patients' journey. It is often preceded by a stage in the progression of heart failure defined as advanced heart failure, and characterised by poor quality of life and frequent h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0072fe0f9539d7215e9ed5ca3598750d